David F. Hoffmeister's most recent trade in Glaukos Corporation was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos Corporation | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.00 per share. | 11 Jun 2025 | 25,000 | 31,918 (0%) | 0% | 32 | 800,000 | Common Stock |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 1,723 | 4,750 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 1,723 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 1,254 | 1,254 | - | - | Common Stock | |
| Celanese Corp - Ordinary S... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 3,376 | 4,490 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 3,149 | 3,149 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,108 | 6,918 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 557 | 4,810 (0%) | 0% | 0 | Common Stock | |
| StepStone Group Inc - Ordi... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 3,926 | 10,243 | - | - | Class A Common Stock | |
| StepStone Group Inc - Ordi... | David F. Hoffmeister | Director | Purchase of securities on an exchange or from another person at price $ 44.29 per share. | 30 May 2024 | 22,500 | 45,853 | - | 44.3 | 996,525 | Class A Common Stock |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1,716 | 7,483 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1,246 | 1,246 | - | - | Stock Option (Right to Buy) | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 1,723 | 0 | - | - | Common Stock | |
| Celanese Corp - Ordinary S... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 156.96 per share. | 15 May 2024 | 1,114 | 1,114 (0%) | 0% | 157.0 | 174,853 | Common Stock |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 948 | 3,027 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 948 | 0 | - | - | Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.28 per share. | 10 Apr 2024 | 10,000 | 15,767 (0%) | 0% | 7.3 | 72,750 | Common Stock |
| Glaukos Corporation | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | F. David Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,082 | 7,399 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,230 | 29,631 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 948 | 948 | - | - | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 485 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 485 | 2,079 (0%) | 0% | 0 | Common Stock | |
| Celanese Corp - Ordinary S... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 98.46 per share. | 12 May 2023 | 1,777 | 50,270 (0%) | 0% | 98.5 | 174,963 | Common Stock |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,572 | 26,401 (0%) | 0% | 0 | Common Stock | |
| StepStone Group Inc - Ordi... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 6,053 | 17,036 | - | - | Class A Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,364 | 24,829 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 1,270 | 1,270 | - | - | Non-Quakified Stock Option (right to buy) | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 485 | 485 | - | - | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 433 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 433 | 1,594 (0%) | 0% | 0 | Common Stock | |
| Celanese Corp - Ordinary S... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 145.68 per share. | 03 May 2022 | 1,098 | 48,493 (0%) | 0% | 145.7 | 159,957 | Common Stock |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,455 | 20,465 (0%) | 0% | 0 | Common Stock | |
| StepStone Group Inc - Ordi... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 3,205 | 10,983 | - | - | Class A Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 2,382 | 19,010 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 1,295 | 1,295 | - | - | Non-Qualified Stock Options (right to buy) | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 468 | 1,161 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 468 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 433 | 433 | - | - | Common Stock | |
| Celanese Corp - Ordinary S... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 975 | 47,395 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 980 | 16,628 (0%) | 0% | 0 | Common Stock | |
| StepStone Group Inc - Ordi... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 2,178 | 7,778 | - | - | Class A Common Stock | |
| StepStone Group Inc - Ordi... | David F. Hoffmeister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2020 | 5,600 | 5,600 | - | - | Class A Common Stock |